Holen Sie sich die Stockscreener-App
2.90
1.02%
-0.03
Vorhandelsmarkt:
2.97
0.07
+2.41%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Altimmune Inc Aktie (ALT) Neueste Nachrichten
Here's why you should add Altimmune stock to your portfolio now - MSN
Altimmune's Q1 loss narrower than expected, revenues nil - MSN
Here's Why You Should Add Altimmune Stock to Your Portfolio Now - Yahoo Finance
Altimmune Q3 2025 Earnings Preview - MSN
ALT Stock Price, Quote & Chart | ALTIMMUNE INC (NASDAQ:ALT) - ChartMill
H.C. Wainwright cuts Altimmune stock price target on dilution - Investing.com India
H.C. Wainwright cuts Altimmune stock price target on dilution By Investing.com - Investing.com South Africa
H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Several Insiders Invested In Altimmune Flagging Positive News - simplywall.st
ALT Maintained by HC Wainwright & Co. -- Price Target Lowered to $20 - GuruFocus
H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Cuts Target Price to $20 - Moomoo
Altimmune Price Target Cut to $20.00/Share From $25.00 by HC Wainwright & Co. - Moomoo
Altimmune Inc Price USD, ALT Price Live Charts, Market Cap & News - Bitget
ALT: Altimmune Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Altimmune Inc (ALT) Stock Price, Quote, News & History - Benzinga
Tang Capital (ALT) reports 666,022 shares, 0.3% stake in Altimmune (ALT) - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
ALT Maintained by Citizens -- Price Target Lowered to $11.00 - GuruFocus
Altimmune Is Maintained at Market Outperform by Citizens - Moomoo
Truist Financial Maintains Altimmune(ALT.US) With Buy Rating - Moomoo
Altimmune's Q1 Loss Narrower Than Expected, Revenues Nil - The Globe and Mail
Altimmune heads to Barcelona for EASL26 to engage global liver disease specialists - Traders Union
A Quick Look at Today's Ratings for Altimmune(ALT.US), With a Forecast Between $11 to $20 - Moomoo
Citizens cuts Altimmune stock price target on increased share count By Investing.com - Investing.com Nigeria
Altimmune, Inc. (NASDAQ:ALT) Q1 2026 Earnings Call Transcript - Insider Monkey
Altimmune shares rise over 3% on beating first quarter loss estimates - Investing.com
Citizens cuts Altimmune stock price target on increased share count - Investing.com
2.98%
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):